Chenguang Biotech Group Handan Co., Ltd. announced a private placement of equity shares for the gross proceeds of CNY 150,000,000 on December 26, 2021. The transaction will involve participation from existing investor ChenGuang Biotech Group Co., Ltd. and it will retain its 100% stake. Post the transaction, the registered capital will increase from CNY 50,000,000 to CNY 200,000,000.

The transaction was approved by investors' board of directors at the 37th Meeting of the company's 4th Directorate, and does not need the Shareholders' Approval.